Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

Clinical trial NCT07190690 · RECRUITING

Trial details

NCT number: NCT07190690
Sponsor: Fundación EPIC
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2025-12-19
Primary completion: 2029-10-15
Enrollment: 2100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.